{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:51:26Z","timestamp":1783021886061,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K25 HL136846"],"award-info":[{"award-number":["K25 HL136846"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL124233"],"award-info":[{"award-number":["R01HL124233"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL089856"],"award-info":[{"award-number":["U01HL089856"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL130512"],"award-info":[{"award-number":["R01HL130512"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","award":["918196"],"award-info":[{"award-number":["918196"]}],"id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Detection of viruses by RNA and DNA sequencing has improved the understanding of the human virome. We sought to identify blood viral signatures through secondary use of RNA-sequencing (RNA-seq) data in a large study cohort. The ability to reveal undiagnosed infections with public health implications among study subjects with available sequencing data could enable epidemiologic surveys and may lead to diagnosis and therapeutic interventions, leveraging existing research data in a clinical context. We detected viral RNA in peripheral blood RNA-seq data from a COPD-enriched population of current and former smokers. Correlation between viral detection and both reported infections and relevant disease outcomes was evaluated. We identified Hepatitis C virus RNA in 228 subjects and HIV RNA in 30 subjects. Overall, we observed 31 viral species, including Epstein-Barr virus and Cytomegalovirus. We observed an enrichment of Hepatitis C and HIV infections among subjects reporting liver disease and HIV infections, respectively. Higher interferon expression scores were observed in the subjects with Hepatitis C and HIV infections. Through secondary use of RNA-seq from a cohort of current and former smokers, we detected peripheral blood viral signatures. We identified HIV and Hepatitis C virus (HCV), highlighting potential public health implications for the approach described this study. We observed correlations with reported infections, chronic infection outcomes and the host transcriptomic response, providing evidence to support the validity of the approach.<\/jats:p>","DOI":"10.1038\/s41598-023-28156-4","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T15:05:09Z","timestamp":1674572709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis C and HIV detection by blood RNA-sequencing in cohort of smokers"],"prefix":"10.1038","volume":"13","author":[{"given":"Jarrett D.","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong H.","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig P.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"28156_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-micro-102215-095431","volume":"70","author":"N Rascovan","year":"2016","unstructured":"Rascovan, N., Duraisamy, R. & Desnues, C. Metagenomics and the human virome in asymptomatic individuals. Annu. Rev. Microbiol. 70, 125\u2013141 (2016).","journal-title":"Annu. Rev. Microbiol."},{"key":"28156_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.immuni.2015.05.003","volume":"42","author":"K Cadwell","year":"2015","unstructured":"Cadwell, K. The virome in host health and disease. Immunity 42, 805\u2013813 (2015).","journal-title":"Immunity"},{"key":"28156_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006292","volume":"13","author":"A Moustafa","year":"2017","unstructured":"Moustafa, A. et al. The blood DNA virome in 8000 humans. PLOS Pathog. 13, e1006292 (2017).","journal-title":"PLOS Pathog."},{"key":"28156_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12915-020-00785-5","volume":"18","author":"R Kumata","year":"2020","unstructured":"Kumata, R., Ito, J., Takahashi, K., Suzuki, T. & Sato, K. A tissue level atlas of the healthy human virome. BMC Biol. 18, 55 (2020).","journal-title":"BMC Biol."},{"key":"28156_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12688\/wellcomeopenres.15499.1","volume":"4","author":"G Magiorkinis","year":"2019","unstructured":"Magiorkinis, G. et al. Potential for diagnosis of infectious disease from the 100,000 genomes project metagenomic dataset: Recommendations for reporting results. Wellcome Open Res. 4, 155 (2019).","journal-title":"Wellcome Open Res."},{"key":"28156_CR6","doi-asserted-by":"publisher","first-page":"19875","DOI":"10.1038\/s41598-021-99238-4","volume":"11","author":"JD Morrow","year":"2021","unstructured":"Morrow, J. D. et al. Peripheral blood microbial signatures in current and former smokers. Sci. Rep. 11, 19875 (2021).","journal-title":"Sci. Rep."},{"key":"28156_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jis927","volume":"207","author":"AY Kim","year":"2013","unstructured":"Kim, A. Y., Onofrey, S. & Church, D. R. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J. Infect. Dis. 207, S1\u2013S6 (2013).","journal-title":"J. Infect. Dis."},{"key":"28156_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12890-020-1114-1","volume":"20","author":"Q Yin","year":"2020","unstructured":"Yin, Q. et al. Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq. BMC Pulm. Med. 20, 81 (2020).","journal-title":"BMC Pulm. Med."},{"key":"28156_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The genotype-tissue expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"28156_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/labinvest.3700135","volume":"84","author":"S Mihm","year":"2004","unstructured":"Mihm, S. et al. Interferon type I gene expression in chronic hepatitis C. Lab. Invest. 84, 1148\u20131159 (2004).","journal-title":"Lab. Invest."},{"key":"28156_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.510240402","volume":"24","author":"J Napoli","year":"1996","unstructured":"Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M. & McCaughan, G. W. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24, 759\u2013765 (1996).","journal-title":"Hepatology"},{"key":"28156_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fimmu.2013.00498","volume":"4","author":"SR Roff","year":"2014","unstructured":"Roff, S. R., Noon-Song, E. N. & Yamamoto, J. K. The significance of interferon-\u03b3 in HIV-1 pathogenesis, therapy, and prophylaxis. Front. Immunol. 4, 498 (2014).","journal-title":"Front. Immunol."},{"key":"28156_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.20411\/pai.v1i1.125","volume":"1","author":"NS Utay","year":"2016","unstructured":"Utay, N. S. & Douek, D. C. Interferons and HIV Infection: The good, the bad, and the ugly. Pathog. Immun. 1, 107\u2013116 (2016).","journal-title":"Pathog. Immun."},{"key":"28156_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","volume":"69","author":"MG Hofmeister","year":"2019","unstructured":"Hofmeister, M. G. et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016. Hepatol. Baltim. Md 69, 1020\u20131031 (2019).","journal-title":"Hepatol. Baltim. Md"},{"key":"28156_CR15","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook, R. H. & Dusheiko, G. Natural history of hepatitis C. J. Hepatol. 61, S58\u2013S68 (2014).","journal-title":"J. Hepatol."},{"key":"28156_CR16","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report, 2019. vol. 32 http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html (2021)."},{"key":"28156_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","volume":"20","author":"CY Chiu","year":"2019","unstructured":"Chiu, C. Y. & Miller, S. A. Clinical metagenomics. Nat. Rev. Genet. 20, 341\u2013355 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"28156_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2011","unstructured":"Regan, E. A. et al. Genetic epidemiology of COPD (COPDGene) study design. COPD J. Chronic Obstr. Pulm. Dis. 7, 32\u201343 (2011).","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"28156_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12920-017-0295-9","volume":"10","author":"MM Parker","year":"2017","unstructured":"Parker, M. M. et al. RNA sequencing identifies novel non-coding RNA and exon-specific effects associated with cigarette smoking. BMC Med. Genomics 10, 58 (2017).","journal-title":"BMC Med. Genomics"},{"key":"28156_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"28156_CR21","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The subread aligner: Fast, accurate and scalable read mapping by seed-and-vote. Nucl. Acids Res. 41, e108\u2013e108 (2013).","journal-title":"Nucl. Acids Res."},{"key":"28156_CR22","doi-asserted-by":"publisher","first-page":"D574","DOI":"10.1093\/nar\/gkv1209","volume":"44","author":"PJ Kersey","year":"2016","unstructured":"Kersey, P. J. et al. Ensembl genomes 2016: More genomes, more complexity. Nucl. Acids Res. 44, D574\u2013D580 (2016).","journal-title":"Nucl. Acids Res."},{"key":"28156_CR23","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1093\/bioinformatics\/bty501","volume":"34","author":"MA Walker","year":"2018","unstructured":"Walker, M. A. et al. GATK PathSeq: A customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts. Bioinformatics 34, 4287\u20134289 (2018).","journal-title":"Bioinformatics"},{"key":"28156_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"28156_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf. 14, 7 (2013).","journal-title":"BMC Bioinf."},{"key":"28156_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/jir.2012.0037","volume":"33","author":"CR Bolen","year":"2013","unstructured":"Bolen, C. R. et al. The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response. J. Interferon Cytokine Res. 33, 15\u201323 (2013).","journal-title":"J. Interferon Cytokine Res."},{"key":"28156_CR27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1086\/430321","volume":"191","author":"CF Ockenhouse","year":"2005","unstructured":"Ockenhouse, C. F., Bernstein, W. B., Wang, Z. & Vahey, M. T. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J. Infect. Dis. 191, 2064\u20132074 (2005).","journal-title":"J. Infect. Dis."},{"key":"28156_CR28","doi-asserted-by":"publisher","unstructured":"Palm, A. A. et al. Interferon alpha-inducible protein 27 expression is linked to disease severity in chronic infection of both HIV-1 and HIV-2. Front. Virol. 2, https:\/\/doi.org\/10.3389\/fviro.2022.929053 (2022).","DOI":"10.3389\/fviro.2022.929053"},{"key":"28156_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/07853890.2021.1995624","volume":"54","author":"H Huang","year":"2022","unstructured":"Huang, H. et al. IFI27 is a potential therapeutic target for HIV infection. Ann. Med. 54, 314\u2013325 (2022).","journal-title":"Ann. Med."},{"key":"28156_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114438","volume":"9","author":"N Putcha","year":"2014","unstructured":"Putcha, N. et al. A simplified score to quantify comorbidity in COPD. PLoS ONE 9, e114438 (2014).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28156-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28156-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28156-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T13:37:53Z","timestamp":1679492273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28156-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28156"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28156-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"10 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Castaldi has received consulting fees and grant support from GSK. Dr. Hersh has received grant support from Bayer, Boehringer-Ingelheim, Novartis and Vertex, and Consulting fees from Astra-Zeneca and Takeda. In the past three years, Edwin K. Silverman has received grant support from GSK and Bayer. All other authors declare that they have no competing interests related to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1357"}}